247 publications
Abemaciclib (Verzenios®) for the treatment of metastatic breast cancer
Zorginstituut Nederland has completed its assessment of abemaciclib (Verzenios®) for the treatment of metastatic breast cancer. ...
Axicabtagene ciloleucel (Yescarta®) for the treatment of adult patients with recurring or refractory diffuse large-cell B-cell lymphoma (DLBCL) and primary mediastinal large-cell B-cell lymphoma (PMBCL)
Zorginstituut Nederland carried out an assessment of the medicinal product axicabtagene ciloleucel (axi-cel, Yescarta®) for the ...
Tisagenlecleucel (Kymriah®) for the treatment of DLBCL
Zorginstituut Nederland has completed its assessment of tisagenlecleucel (Kymriah®) for the treatment of DLBCL. Due to its ...
Patiromer (Veltassa®) for the treatment of hyperkalaemia in adults
Zorginstituut Nederland has carried out an assessment whether patiromer (Veltassa®) is interchangeable with a medicinal product ...
Tisagenlecleucel-T (Kymriah®) for the treatment of ALL
Zorginstituut Nederland carried out an assessment of the medicinal product tisagenlecleucel-T (Kymriah®) for the treatment of ...
Lesinurad (Zurampic®) for the treatment of hyperuricaemia in gout patients
Zorginstituut Nederland carried out an assessment whether lesinurad (Zurampic®) is interchangeable with any product that is ...
Letermovir (Prevymis®) in cases of adult CMV-seropositive recipients of an allogenic haemotopoietic stem cell transplant (HSCT)
Zorginstituut Nederland has carried out an assessment whether letermovir (Prevymis®) is interchangeable with a medicinal product ...
Final report FAIR Data feasibility assessment
This is the final report of the FAIR Data part of the FAIR Data and Personal Health Train feasibility assessment. In this ...
Final report on the Personal Health Train feasibility assessment
This is the final report of the FAIR Data part of the feasibility assessment on FAIR Data & the Personal Health Train (PHT). In ...
Zinnige Zorg in-depth phase appropriate post-treatment surveillance of patients with non-melanoma skin cancer or actinic keratosis - letter to Minister
As part of the Zinnige Zorg programme, Zorginstituut Nederland started the in-depth phase of appropriate post-treatment ...